Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, H. Itakura, T. Kita, A. Kitabatake, N. Nakaya, T. Sakata, K. Shimada, K. Shirato (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisThe Lancet, 369
Marchioli R, Schweiger C, Tavazzi L, Valagussa F (2001)
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico.Lipids, 36
M. Burr, J. Gilbert, R. Holliday, P. Elwood, A. Fehily, S. Rogers, P. Sweetnam, N. Deadman (1989)
EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)The Lancet, 334
D. Kromhout, E. Giltay, J. Geleijnse (2010)
n-3 fatty acids and cardiovascular events after myocardial infarction.The New England journal of medicine, 363 21
R. Marchioli, C. Schweiger, L. Tavazzi, F. Valagussa (2001)
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI-prevenzione trialLipids, 36
S. Kwak, S. Myung, Young Lee, H. Seo (2012)
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.Archives of internal medicine, 172 9
In reply We appreciate the letter of DiNicolantonio et al in response to our report1 in the Archives. We acknowledge that several methodologic issues raised by DiNicolantonio et al are important for our main conclusions. First, regarding the small sample size and short follow-up period, we stated in the limitations of the “Comment” section1(p693) that Fifth, most trials included in the present meta-analysis had a small sample size of 59 to 500 participants and a short duration of treatment of less than 2 to 3 years. Further larger trials are needed. However, although we included trials with a small sample size of participants, the number of total participants in the meta-analysis was more than 20 000, which is regarded as having enough power to detect a difference in cardiovascular outcomes. Second, regarding the exclusion of the 5 trials with the use of olive oil as a control group, when we performed a subgroup meta-analysis with excluding those 5 trials, no preventive effect of omega-3 fatty acid supplementation on overall cardiovascular events was observed (relative risk [RR], 0.94; 95% CI, 0.83-1.07). Also, when we performed a meta-analysis without the trial by Kromhout et al2 that used margarine spread, there was no preventive effect (RR, 0.98; 95% CI, 0.86-1.11). Third, the Diet and Reinfarction Trial (DART)3 that DiNicolantonio et al mentioned is not a relevant trial for our meta-analysis because it used only advice on an increase in fatty fish intake, not omega-3 fatty acid supplementation. Last, regarding the exclusion of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione4 and Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS)5 in our analysis, we already addressed in the “Comment” section. Again, the main reason that we excluded those 2 large randomized controlled trials is that they used an open-label design without using placebos, which is liable to performance bias. For the readers who have the same question, in our article1(p691) we already mentioned that When we performed a meta-analysis with the GISSI-Prevenzione trial[4] and the JELIS[5] in addition to the 14 trials included in the present study, a preventive effect of omega-3 fatty acid supplementation was not observed (RR, 0.95; 95% CI, 0.87-1.03; I2=35.5%) (data not shown). In conclusion, despite some methodologic issues and limitations, our meta-analysis indicates that there is a lack of sufficient evidence of the secondary preventive effects of omega-3 supplementation on cardiovascular disease. Further larger randomized, double-blind, placebo-controlled trials are needed to confirm our findings. Back to top Article Information Correspondence: Dr Myung, Carcinogenesis Branch, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, Republic of Korea (msk@ncc.re.kr). Financial Disclosure: None reported. References 1. Kwak SM, Myung SK, Lee YJ, Seo HG.Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012;172(9):686-69422493407PubMedGoogle Scholar 2. Kromhout D, Giltay EJ, Geleijnse JM.Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363(21):2015-202620929341PubMedGoogle ScholarCrossref 3. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757-7612571009PubMedGoogle Scholar 4. Marchioli R, Schweiger C, Tavazzi L, Valagussa F.Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. Lipids. 2001;36:(suppl) S119-S12611837985PubMedGoogle Scholar 5. Yokoyama M, Origasa H, Matsuzaki M, et al; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090-109817398308PubMedGoogle Scholar
Archives of Internal Medicine – American Medical Association
Published: Oct 8, 2012
Keywords: omega-3 fatty acids,fish oils
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.